What is PMOS?

What is PMOS?

Despite what the name suggests, Polyendocrine Metabolic Ovarian Syndrome isn’t just about ovaries—or cysts, for that matter. In fact, many people diagnosed with PMOS don’t have any ovarian cysts at all. Confusing? You’re not alone. The name dates back to how the condition was first described, but science has come a long way since then. Today, we understand that PCOS is really a complex hormonal and metabolic condition that affects far more than reproductive health.

At its core, PMOS is about hormonal imbalance. When key hormones like insulin, androgens (like testosterone), and others are out of sync, they can create a domino effect throughout the body. This hormonal miscommunication can lead to irregular periods, acne, weight changes, hair loss or excess hair growth, difficulty with ovulation or fertility—and that’s just the shortlist. But here’s the thing: PMOS doesn’t follow a single pattern. Some women experience textbook symptoms. Others don’t fit the mold at all. That’s part of what makes PMOS so challenging—and why understanding your unique experience matters.

So, how can the PMOS Association help?

We’re here to offer more than definitions. We’re here to offer direction. Whether you’re newly diagnosed, still searching for answers, or years into your journey and feeling stuck, we’re committed to helping you make sense of PMOS—and make progress.

Here’s what you’ll find at PMOSA:

  • ✅ Reliable, science-backed information about what PMOS is (and isn’t)

  • 💬 Supportive communities of people who understand exactly what you’re going through

  • 🧬 Resources for navigating fertility, metabolic health, nutrition, and more

  • 🧠 Education for providers who want to better support their PMOS patients

  • 🙋‍♀️ Advocacy to make sure PMOS is recognized, researched, and respected

No fluff. No fad cures. Just real support, grounded in evidence and compassion.

At PMOSA, we believe every person with PCOS deserves to be informed, empowered, and heard. Wherever you are in your journey, we’re honored to walk with you.

pcos

pcos: Latest results from PubMed

The diagnostic value of serum 25-hydroxyvitamin D, MIS, and insulin-like growth factor 1 for polycystic ovary syndrome (PCOS)

CONCLUSIONS: MIS, IGF-1, IGFBP-3, and serum 25(OH)D levels are associated with the development and occurrence of PCOS. The combined detection of these four indicators has high auxiliary diagnostic value for PCOS and is conducive to clinical prevention and treatment.

Published on: Thu, 24 Sep 2026 06:00:00 -0400

Authors: Shaomeng Sun, Jianrui Zheng, Ziying Xie,

A health promotion behavior intervention for women with polycystic ovary syndrome experiencing infertility: a randomized controlled trial

CONCLUSION: The BCW-based intervention program showed promise in improving health promotion behaviors and self-efficacy among PCOS patients with infertility over 12 weeks, although its effect on pregnancy rate was not statistically significant. Longer-term studies are warranted to evaluate sustained benefits and reproductive outcomes.

Published on: Thu, 24 Sep 2026 06:00:00 -0400

Authors: Pingpei Dong, Yongjie Tang, Ting Wang, Yunxi Xue, Xunxun Ying, Yang Jin,

Association of paternal age with embryological outcomes and β-hCG positivity in women with polycystic ovary syndrome undergoing ICSI: a retrospective cohort study

CONCLUSION: Paternal age was not independently associated with β-hCG positivity or with a consistent deterioration in embryological outcomes among women with PCOS undergoing ICSI. Although an overall difference in fertilization rate was observed, this finding was not confirmed by corrected pairwise comparisons. These results should be interpreted cautiously because of the small ≥40-year subgroup and the absence of later pregnancy outcomes and molecular sperm-quality assessments.

Published on: Thu, 24 Sep 2026 06:00:00 -0400

Authors: Fırat Şahin, Mustafa Kemal Özel, Mehmet Uğur Karabat, Zuhal Çankırı, Fırat Aşır, Mehmet Turan Çetin,

Maternal macrovascular and microvascular adaptation in healthy pregnancy, gestational diabetes, and hypertensive disorders of pregnancy

CONCLUSION: HDP is characterized by early alterations in arterial stiffness and positional BP responses, which may improve risk stratification when integrated with FMF algorithm. In contrast, GDM was not associated with overt vascular dysfunction.

Published on: Wed, 23 Sep 2026 06:00:00 -0400

Authors: Lorenzo Annesi, Davide Agnoletti, Emiliana Angilletta, Alessandro Baracchi, Giusy Buccomino, Debora Cromi, Elisa Montaguti, Leonardo Pieri, Gianluigi Pilu, Francesca Rosi, Federico Ruscelli, Sara Scarduelli, Giuliana Simonazzi, Sofia Vincenzi, Claudio Borghi, Federica Piani,

Genetic and Epigenetic Basis of Polycystic Ovary Syndrome:A Systematic Review

CONCLUSION: PCOS should be considered a complex molecular disorder arising from interactions among genetic, epigenetic, metabolic, mitochondrial and endocrine mechanisms rather than from isolated pathogenic pathways. Integrating these mechanisms may improve understanding of disease heterogeneity and support development of more accurate biomarkers and personalized therapeutic strategies. However, clinical relevance of the emerging targets, such as PGK1 and mitochondrial regulatory pathways,...

Published on: Wed, 23 Sep 2026 06:00:00 -0400

Authors: Simin Nafian, Fatemeh Nafian, Zahra Dorri, Pezhman Shafiei Asheghabadi,

Evaluating the Therapeutic Potential of Antioxidants in Polyendocrine Metabolic Ovarian Syndrome (PMOS)-Associated Infertility

CONCLUSION: Antioxidant supplementation may have a complementary role in improving reproductive outcomes in infertile women with PMOS. However, some uncertainty remains given the heterogeneity of the included studies and the limited number of trials for certain antioxidants. Further well-designed randomized controlled studies are required to establish definitive clinical benefit.

Published on: Tue, 22 Sep 2026 06:00:00 -0400

Authors: Pramathes Das Mahapatra, Vidya Vishwanath Bhat, Noopur Ajaykumar Vyas, Shruti Dharmadhikari, Gaurav Puppalwar, Chintan Khandhedia, Amey Mane, Suyog Mehta,

A nomogram for predicting insulin resistance in polycystic ovary syndrome based on serum amino acid profiles and anti-Müllerian hormone

CONCLUSION: This nomogram, integrating anthropometric measures, serum AMH and four amino acids, provides an accurate tool for the early identification of IR in PCOS.

Published on: Tue, 22 Sep 2026 06:00:00 -0400

Authors: Yan Zhao, Haiyang Wang, Cuina Zhang, Hongmei He,

The effect of acupoint catgut embedding combined with cyproterone acetate and ethinylestradiol plus metformin on sex hormones, glycolipid metabolism and insulin resistance in patients with polycystic ovary syndrome

CONCLUSION: Acupoint catgut embedding combined with conventional pharmacotherapy synergistically improves hormonal dysregulation, metabolic disturbances, and insulin resistance in PCOS with a favorable safety profile.

Published on: Tue, 22 Sep 2026 06:00:00 -0400

Authors: Ailing Zhao, Hong Qu, Ming Wei, Xuemei Zhang,

Oxygen Sensing in Plants

Hypoxia in plants is detrimental to plant growth and crop productivity. It typically arises from adverse environmental conditions that limit oxygen availability, thereby restricting mitochondrial respiration. However, hypoxia also occurs in specific plant tissues where oxygen levels are low due to intense respiratory activity or limited oxygen diffusion. Under these conditions, the existence of a molecular oxygen-sensing mechanism directs plant metabolism and developmental pathways, matching...

Published on: Mon, 21 Sep 2026 06:00:00 -0400

Authors: Elena Loreti, Pierdomenico Perata,

Evaluating the Role of Exosome Therapy in Reproductive Aging:A Narrative Review of Recent Advancements

CONCLUSION: Exosome therapy is a promising, non-hormonal option for addressing reproductive aging, with potential for safe and effective clinical use.

Published on: Sun, 20 Sep 2026 06:00:00 -0400

Authors: Elham Sadat Alavi Moghaddam, Hooman Mohammad Talebi,

Systematic Review and Meta-Analysis on the Association Between Cadmium and Mercury, with Polycystic Ovary Syndrome

Polycystic ovary syndrome (PCOS) is a prevalent endocrine disorder with multifactorial etiology. Cadmium (Cd) and mercury (Hg) are potent endocrine-disrupting metals, yet their association with PCOS remains inconsistent. These metals were targeted due to their high prevalence, established ovarian toxicity, and shared mechanistic pathways relevant to PCOS. Following PRISMA guidelines, we searched PubMed, Scopus, Web of Science, and Embase through December 2025 for observational studies comparing...

Published on: Sat, 19 Sep 2026 06:00:00 -0400

Authors: Mehrnoush Matin, Mehdi Koupaee, Mohammad Javad Khodayar,

Gypenosides ameliorate polycystic ovary syndrome via gut microbiota modulation: An integrated gut microbiome and ovarian transcriptome study

Polycystic ovary syndrome (PCOS) is a prevalent endocrine disorder with complex metabolic and reproductive manifestations. Gut microbiota dysbiosis has emerged as a key factor in PCOS, yet the causal role of microbiota-targeted interventions remains to be fully defined. In a letrozole-induced rat model, we show that gypenosides (GPs)-bioactive saponins from Gynostemma pentaphyllum-alleviate weight gain, hormonal imbalance, and estrous cycle disruption, alongside reducing systemic oxidative...

Published on: Sat, 19 Sep 2026 06:00:00 -0400

Authors: Shaorong Li, Jiangfan Wan, Zhijie Liang, Jinzhuai Li, Hongmian Jiang, Lifeng Luo, Yingying Li, Shuying Luo, Huali Huang,

Plant Flavonoid-Enriched Functional Foods for Polycystic Ovary Syndrome: Dietary Sources, Bioavailability Enhancement, and Personalized Intervention Strategies

Plant flavonoids are polyphenolic compounds widely found in fruits, vegetables, tea, legumes, and medicinal and edible plants; they are important natural functional components in food. These compounds play a significant role in various biological activities, such as alleviating inflammation, regulating insulin sensitivity, and improving glucose and lipid metabolism, making them ideal candidates for the development of functional foods and dietary intervention strategies aimed at balancing...

Published on: Sat, 19 Sep 2026 06:00:00 -0400

Authors: Jianding Wang, Hejian Zhu, Qing Shen, Yinghua Zhong, Yunli Du, Wenxi Yu, Fang Mao, Zhitao Yao, Weiwei Zhu, Lirong Sun, Qiu Lin, Xiaomin Xu, Jiong Zhu,

Adult psychological outcomes among women with different adolescent PCOS presentations

CONCLUSIONS: Adult women diagnosed with PCOS (Rotterdam phenotypes A and B) in adolescence did not exhibit poorer quality of life or increased depressive symptoms compared with women presenting Rotterdam PCOS phenotypes C and D or adolescents previously classified as being at risk of PCOS. No significant differences were observed between groups in PHQ-9 or WHOQOL-BREF scores, nor were these outcomes related to BMI, hyperandrogenism, or disease duration. Both groups demonstrated elevated...

Published on: Sat, 19 Sep 2026 06:00:00 -0400

Authors: Maria Małgorzata Nowak-Ciołek, Julia Paczyna, Katarzyna Grygiel, Julia Sokal, Żaneta Malczyk, Karolina Skrzyńska, Agnieszka Zachurzok,

Hypothalamic Epac2/AKT/GnRH signalling is associated with metformin-responsive neuroendocrine improvement in a PCOS model

CONCLUSIONS: These findings support the involvement of hypothalamic Epac2/AKT/GnRH signalling in metformin-responsive neuroendocrine regulation in PCOS. Further studies are required to determine the relative contributions of central and peripheral mechanisms.

Published on: Fri, 18 Sep 2026 06:00:00 -0400

Authors: Na Guo, Hongyun Li, Jinhong He, Huanhuan Zhou, Xing Wang, Linlin Yang, Huijuan Ma,